AstraZeneca commits to CRISPR gene-editing collaboration
AstraZeneca has joined up with academic and industrial research partners to use CRISPR, a new and much-hyped gene-editing technology in their quest for new medicines....
Claire Downes was previously a Volunteer Writer at BioNews. She also works in Research and Development Quality for a generic pharmaceutical company, and has worked in clinical trial drug safety as a pharmacovigilance associate. She originally studied Psychology and Information Technology at the National University of Ireland in Galway, where she went on to obtain an MSc in Neuorpharmacology. She has a particular interest in developmental and biological psychology, and in neurological disorders and interventions.
AstraZeneca has joined up with academic and industrial research partners to use CRISPR, a new and much-hyped gene-editing technology in their quest for new medicines....
Researchers have identified a connection between DNA methylation and Alzheimer's disease, gaining a further understanding into the underlying causes of this neurodegenerative condition....
The shortage of transplantable lungs available for people with end-stage lung disease is being addressed in a new project led by genome scientist Dr Craig Venter...
Lifestyle and environmental factors can alter sensitivity to pain by switching certain genes on or off, according to research from King’s College London...
A single gene linked to morbid obesity in a family in Israel also causes obesity and diabetes when deleted in mice...
Transplanting people's own stem cells along with their fat could mean more stable transplants in reconstructive breast surgery, a small preliminary trial suggests...
Stay up-to-date on all the latest developments in the fields of human fertility and genomics. And be the first to hear about upcoming events and other announcements.